Vanguard Group Inc Biolife Solutions Inc Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Biolife Solutions Inc stock. As of the latest transaction made, Vanguard Group Inc holds 2,836,257 shares of BLFS stock, worth $71.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,836,257
Previous 2,848,326
0.42%
Holding current value
$71.4 Million
Previous $71.3 Million
3.28%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding BLFS
# of Institutions
188Shares Held
47.1MCall Options Held
4.3KPut Options Held
4.7K-
Casdin Capital, LLC New York, NY8.71MShares$219 Million19.45% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$138 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.24MShares$81.5 Million0.02% of portfolio
-
Fred Alger Management, LLC New York, NY1.59MShares$40.1 Million0.21% of portfolio
-
State Street Corp Boston, MA1.47MShares$37 Million0.0% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.07B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...